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Simvastatin prevents dopaminergic neurodegeneration in experimental 
parkinsonian models: the association with anti-inflammatory responses 
Abstract 
Background: In addition to their original applications to lowering cholesterol, statins display multiple 
neuroprotective effects. N-methyl-D-aspartate (NMDA) receptors interact closely with the dopaminergic 
system and are strongly implicated in therapeutic paradigms of Parkinson’s disease (PD). This study aims 
to investigate how simvastatin impacts on experimental parkinsonian models via regulating NMDA 
receptors. Methodology/Principal Findings: Regional changes in NMDA receptors in the rat brain and 
anxiolytic-like activity were examined after unilateral medial forebrain bundle lesion by 
6-hydroxydopamine via a 3-week administration of simvastatin. NMDA receptor alterations in the post-
mortem rat brain were detected by [3H]MK-801(Dizocilpine) binding autoradiography. 6-hydroxydopamine 
treated PC12 was applied to investigate the neuroprotection of simvastatin, the association with NMDA 
receptors, and the anti-inflammation. 6-hydroxydopamine induced anxiety and the downregulation of 
NMDA receptors in the hippocampus, CA1(Cornu Ammonis 1 Area), amygdala and caudate putamen was 
observed in 6- OHDA(6-hydroxydopamine) lesioned rats whereas simvastatin significantly ameliorated the 
anxiety-like activity and restored the expression of NMDA receptors in examined brain regions. Significant 
positive correlations were identified between anxiolytic-like activity and the restoration of expression of 
NMDA receptors in the hippocampus, amygdala and CA1 following simvastatin administration. 
Simvastatin exerted neuroprotection in 6-hydroxydopamine-lesioned rat brain and 6- hydroxydopamine 
treated PC12, partially by regulating NMDA receptors, MMP9 (matrix metalloproteinase-9), and TNF-a 
(tumour necrosis factor-alpha). Conclusions/Significance: Our results provide strong evidence that NMDA 
receptor modulation after simvastatin treatment could partially explain its anxiolytic-like activity and anti-
inflammatory mechanisms in experimental parkinsonian models. These findings contribute to a better 
understanding of the critical roles of simvastatin in treating PD via NMDA receptors. 
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